Safety and Tolerability of Single and Multiple Doses of Neumifil

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a Phase 1, single-centre, randomised, placebo-controlled first in human study in healthy subjects. The study will assess the safety and tolerability of single-ascending (Part A) and multiple-ascending (Part B) doses of Neumifil, administered intranasally.
Epistemonikos ID: e49c927f6184a1734de38f4fff0587f3e3e5a7ea
First added on: Oct 27, 2021